COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > Cambridge Philosophical Society > Molecular medicines for the lysosome
Molecular medicines for the lysosomeAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Beverley Larner. Abstract: This year saw the award of the third Nobel prize for research into the cell biology of the lysosome: an organelle for defence, recycling and energy-sensing of the metabolic economy. Critical functions of lysosomes are revealed by the astonishing clinical diversity of genetic defects in this organelle – many of these rare diseases affect the brain. We are learning much about common conditions, such as myeloma and Parkinson disease, from their study. Lysosomes may be accessed by proteins delivered at the cell surface and the spectacular success of macrophage-targeted enzyme therapy for Gaucher disease has stimulated development of inhibitors that rebalance defective lysosomal substrate recycling. The diseased brain remains a formidable challenge but gene therapy is promising and in early clinical development. This talk is part of the Cambridge Philosophical Society series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other liststo be confirmed Three-dimensional cell culture: Innovations in tissue scaffolds and biomimetic systems Information Structure All Faculty of Education Seminars Field Archaeology: Methods and Mayhem Philiminality CambridgeOther talksOncological imaging: introduction and non-radionuclide techniques Modularity, criticality and evolvability of a developmental GRN Single Molecule Spectroscopy TALK CANCELLED Targets for drug discovery: from target validation to the clinic CANCELLED DUE TO STRIKE ACTION Concentrated, “pulsed” axial glacier flow: structural glaciological evidence from Kvíárjökull in SE Iceland |